Oncolytics Biotech Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q2 2024 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q3 2024 | 2 | -$0.12 | -$0.10 | -$0.11 |
| Q1 2025 | 2 | -$0.11 | -$0.11 | -$0.11 |
| Q2 2025 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q3 2025 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q4 2025 | 1 | -$0.10 | -$0.10 | -$0.10 |
Oncolytics Biotech Inc. Earnings Date And Information
Oncolytics Biotech Inc. last posted its earnings results on Thursday, August 1st, 2024. The company reported $-0.07 earnings per share for the quarter, topping analysts' consensus estimates of $-0.08 by $0.01. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Oncolytics Biotech Inc. has generated $0 earnings per share over the last year ($-0.41 diluted earnings per share) and currently has a price-to-earnings ratio of -3.79. Oncolytics Biotech Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 15th, 2024 based on prior year's report dates.
Oncolytics Biotech Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.13 | $0 | $0 | ||
| 08/01/2024 | Q2 2024 | -$0.08 | -$0.10 | -0.02 | $0 | $0 |
| 03/07/2024 | Q1 2024 | -$0.11 | -$0.09 | 0.02 | $0 | |
| 11/03/2023 | Q4 2023 | -$0.07 | -$0.05 | 0.02 | $0 | |
| 08/14/2023 | Q3 2023 | -$0.09 | -$0.14 | -0.05 | $0 | |
| 05/05/2023 | Q2 2023 | -$0.07 | -$0.12 | -0.05 | $0 | |
| 03/03/2023 | Q1 2023 | -$0.05 | -$0.10 | -0.05 | $0 | |
| 11/07/2022 | Q4 2022 | -$0.09 | -$0.14 | -0.05 | $0 | |
| 08/11/2022 | Q3 2022 | -$0.09 | -$0.08 | 0.01 | $0 | |
| 05/05/2022 | Q2 2022 | -$0.13 | -$0.09 | 0.04 | $0 | |
| 03/03/2022 | Q1 2022 | -$0.14 | -$0.14 | 0 | $0 | |
| 11/05/2021 | Q4 2021 | -$0.15 | -$0.14 | 0.01 | $0 | |
| 08/06/2021 | Q3 2021 | -$0.10 | -$0.09 | 0.01 | $0 | |
| 05/07/2021 | Q2 2021 | -$0.17 | -$0.13 | 0.04 | $0 | |
| 03/05/2021 | Q1 2021 | -$0.13 | -$0.13 | 0 | $0 | |
| 03/05/2021 | Q4 2020 | -$0.13 | -$0.22 | -0.09 | $0 | |
| 11/12/2020 | Q3 2020 | -$0.16 | $0 | |||
| 05/08/2020 | Q2 2020 | -$0.14 | -$0.17 | -0.03 | $0 | |
| 03/05/2020 | Q1 2020 | -$0.11 | $0.01 | 0.12 | $0 | |
| 03/06/2020 | Q4 2019 | -$0.54 | $0 |
Oncolytics Biotech Inc. Earnings: Frequently Asked Questions
-
When is Oncolytics Biotech Inc.'s earnings date?
Oncolytics Biotech Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 15th, 2024 based off last year's report dates.
-
Did Oncolytics Biotech Inc. beat their earnings estimates last quarter?
In the previous quarter, Oncolytics Biotech Inc. (:ONCY) reported $-0.07 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.08 by $0.01.
-
How can I listen to Oncolytics Biotech Inc.'s earnings conference call?
The conference call for Oncolytics Biotech Inc.'s latest earnings report can be listened to online.
-
How can I read Oncolytics Biotech Inc.'s conference call transcript?
The conference call transcript for Oncolytics Biotech Inc.'s latest earnings report can be read online.
-
How much profit does Oncolytics Biotech Inc. generate each year?
Oncolytics Biotech Inc. (:ONCY) has a recorded net income of $0. Oncolytics Biotech Inc. has generated $-0.41 earnings per share over the last four quarters.
-
What is Oncolytics Biotech Inc.'s price-to-earnings ratio?
Oncolytics Biotech Inc. (:ONCY) has a price-to-earnings ratio of -3.79 and price/earnings-to-growth ratio is -0.1.
